Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells (Q46182219)

20 December 2017

title

Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells (English)

1 reference

20 December 2017

1 reference

acute myeloid leukemia

1 reference

Noura M El Kholy

1 reference

20 December 2017

Maha M Sallam

1 reference

20 December 2017

Manal B Ahmed

1 reference

20 December 2017

Reem M Sallam

1 reference

20 December 2017

Inas A Asfour

1 reference

20 December 2017

Jehad A Hammouda

1 reference

20 December 2017

Haidy Z Habib

1 reference

20 December 2017

Fatima Abu-Zahra

1 reference

20 December 2017

publication date

19 March 2010

1 reference

20 December 2017

published in

Medical Oncology

1 reference

20 December 2017

volume

1 reference

20 December 2017

issue

1 reference

20 December 2017

page(s)

270-278

1 reference

20 December 2017

Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

The tumor-draining lymph node as an immune-privileged site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

A new, simple, bioassay for human IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

T cell homeostatic proliferation elicits effective antitumor autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

Prevention of spontaneous tumor development in a ret transgenic mouse model by ret peptide vaccination with indoleamine 2,3-dioxygenase inhibitor 1-methyl tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9459-6

[Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape]

21 January 2018

1 reference

12 December 2020

Tryptophan catabolism and T cell responses.

1 reference

12 December 2020

Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy.

1 reference

12 December 2020

Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection

1 reference

12 December 2020

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

12 December 2020

Advances in understanding the biology and genetics of acute myelocytic leukemia

1 reference

12 December 2020

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

12 December 2020

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function

1 reference

12 December 2020

10.1007/S12032-010-9459-6

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017